Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-22
DOI
10.3389/fendo.2020.609895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
- (2020) Giulia Lanzolla et al. Frontiers in Endocrinology
- Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study
- (2020) G. Lanzolla et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
- (2019) Xiaoquan Rao et al. EBioMedicine
- Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
- (2019) Yao Wang et al. Therapeutics and Clinical Risk Management
- Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism
- (2018) Wilmar Wiersinga et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study
- (2018) Elena Sabini et al. THYROID
- Glucocorticoids, Sex Hormones, and Immunity
- (2018) Oxana Bereshchenko et al. Frontiers in Immunology
- Comparison of Low-density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation
- (2018) Seth S. Martin et al. JAMA Cardiology
- Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
- (2018) M. Marinò et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis
- (2018) Raymond S. Douglas EYE
- Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone
- (2017) Yehoshua Enuka et al. NUCLEIC ACIDS RESEARCH
- Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?
- (2017) L. Bartalena et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy
- (2015) Lijing Xing et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy
- (2015) R. Le Moli et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves Disease
- (2015) Joshua D. Stein et al. JAMA Ophthalmology
- Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury – Rescue by High-Dose Statin Treatment
- (2013) Marco Busnelli et al. PLoS One
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy
- (2012) Terry J. Smith et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of the glucocorticoid receptor in inflammation and immunity
- (2010) Ulrike Baschant et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Risk Factors for Development or Deterioration of Graves' Ophthalmopathy
- (2010) Marius N. Stan et al. THYROID
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
- (2008) Luigi Bartalena et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started